Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3968387
Max Phase: Preclinical
Molecular Formula: C19H13F2NO4
Molecular Weight: 357.31
Molecule Type: Small molecule
Associated Items:
ID: ALA3968387
Max Phase: Preclinical
Molecular Formula: C19H13F2NO4
Molecular Weight: 357.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(c1ccc(F)c(O)c1)c1cc(CO)cc(-c2cccc(O)c2F)n1
Standard InChI: InChI=1S/C19H13F2NO4/c20-13-5-4-11(8-17(13)25)19(26)15-7-10(9-23)6-14(22-15)12-2-1-3-16(24)18(12)21/h1-8,23-25H,9H2
Standard InChI Key: AGLYTRDSFIYAQW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 357.31 | Molecular Weight (Monoisotopic): 357.0813 | AlogP: 3.16 | #Rotatable Bonds: 4 |
Polar Surface Area: 90.65 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.46 | CX Basic pKa: 0.69 | CX LogP: 3.54 | CX LogD: 3.24 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.62 | Np Likeness Score: -0.04 |
1. Braun F, Bertoletti N, Möller G, Adamski J, Steinmetzer T, Salah M, Abdelsamie AS, van Koppen CJ, Heine A, Klebe G, Marchais-Oberwinkler S.. (2016) First Structure-Activity Relationship of 17β-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal Inhibitors and Crystal Structures in Complex with the Enzyme., 59 (23): [PMID:27933965] [10.1021/acs.jmedchem.6b01436] |
Source(1):